Aristo Bio-Tech and Lifescience Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDChemicals
The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.
PROS
- Company has delivered good profit growth of 32.2% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.29x)
- Working capital cycle has improved - days down from 32 to 23
- Company generates healthy free cash flow
- Attractively priced for its growth - PEG of 0.2
CONS
- Equity base is being diluted - shares outstanding up 36.3%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| UPL | 576.05 | 24.07 | 48628.37 | 1.04 | -73.00 | 58.52 | 10181.00 | 10.47 | 12.00 | 13.43 |
| PIIND | 2390.55 | 31.13 | 36268.97 | 0.63 | 244.20 | -38.95 | 1702.30 | -10.43 | 16.00 | 21.69 |
| SUMICHEM | 505.00 | 43.50 | 25206.86 | 0.26 | 214.51 | 20.45 | 1063.35 | 0.62 | 23.39 | 21.94 |
| BAYERCROP | 3980.70 | 322.87 | 17890.10 | 3.77 | 321.60 | 15.39 | 1835.00 | -4.16 | 30.08 | 20.03 |
| SHARDACROP | 778.45 | 11.22 | 7023.21 | 1.93 | 88.02 | -38.36 | 1073.77 | 9.03 | 31.10 | 17.32 |
| DHANUKA | 994.20 | 14.92 | 4431.98 | 0.20 | 75.50 | 27.94 | 442.02 | 20.01 | 24.44 | 24.83 |
| RALLIS | 209.55 | 24.82 | 4075.10 | 1.43 | -14.15 | -274.26 | 507.54 | 7.70 | 13.23 | -0.56 |
| NACLIND | 167.45 | 317.09 | 3922.40 | 0.00 | 20.84 | 59.82 | 383.33 | -14.50 | 6.20 | 10.80 |
| BHAGCHEM | 267.95 | 126.24 | 3474.48 | 0.06 | 133.29 | 3249.84 | 1950.19 | 1475.55 | 4.55 | 15.65 |
| GSPCROP | 626.60 | 29.78 | 2914.86 | 0.16 | 263.94 | 1111.46 | 3859.95 | 1153.27 | 18.46 | 11.02 |
| BHARATRAS | 1204.30 | 13.97 | 2001.68 | 0.04 | 372.30 | 838.73 | 3381.60 | 796.03 | 16.63 | 15.19 |
| ARISTO | 103.00 | 9.76 | 70.12 | 0.58 | — | — | — | — | 12.96 | — |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 202 | 201 | 167 | 166 | 218 | 245 | 318 | |
| 195 | 197 | 163 | 161 | 209 | 237 | 309 | |
| Operating Profit | 7 | 5 | 5 | 5 | 9 | 9 | 10 |
| OPM % | 3 | 2 | 3 | 3 | 4 | 4 | 3 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest | 2 | 3 | 2 | 2 | 3 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 3 |
| 4 | 1 | 1 | 2 | 5 | 5 | 5 | |
| Tax % | 31 | 28 | 28 | 28 | 25 | 28 | 26 |
| Net Profit | 3 | 1 | 1 | 1 | 4 | 4 | 4 |
| EPS | 6 | 2 | 2 | 3 | 7 | 6 | 6 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 5 | 7 | 8 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 6 | 2 | 2 | 3 | 5 | 6 | 6 |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 10%
- 3 Years:
- 24%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 32%
- 3 Years:
- 42%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 6%
- 1 Year:
- -21%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 12%
- 3 Years:
- 13%
- Last Year:
- 11%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - |
| Equity Capital | 5 | 5 | 5 | 5 | 7 | 7 | 7 |
| 6 | 7 | 8 | 10 | 23 | 27 | 31 | |
| 6 | 8 | 9 | 13 | 10 | 8 | 11 | |
| Trade Payables | 63 | 38 | 38 | 35 | 45 | 69 | 78 |
| 11 | 30 | 20 | 14 | 14 | 16 | 14 | |
| Total Liabilities | 91 | 88 | 81 | 77 | 100 | 127 | 141 |
| ASSETS | - | - | - | - | - | - | - |
| 8 | 8 | 12 | 14 | 16 | 22 | 24 | |
| Capital Work in Progress | 1 | 3 | 0 | 0 | 1 | 0 | 0 |
| 33 | 24 | 32 | 24 | 31 | 40 | 47 | |
| 0 | 0 | 0 | 0 | 0 | 57 | 56 | |
| Cash & Bank | 0 | 1 | 0 | 0 | 2 | 1 | 1 |
| 48 | 52 | 37 | 38 | 50 | 7 | 12 | |
| Total Assets | 91 | 88 | 81 | 77 | 100 | 127 | 141 |
| Total Debt | 14 | 20 | 22 | 25 | 22 | 21 | 22 |
| Net Working Capital | 9 | 12 | 13 | 12 | 23 | 21 | 20 |
| Contingent Liabilities | 2 | 1 | 0 | 1 | 1 | 0 | 0 |
| Book Value per Share | 22.62 | 24.63 | 26.79 | 29.76 | 44.30 | 49.37 | 54.84 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 8 | 1 | 2 | 7 | -3 | 8 | 10 | |
| Cash from Investing | -2 | -2 | -2 | -3 | -4 | -7 | -5 |
| Cash from Financing | -6 | 1 | -1 | -3 | 8 | -2 | -4 |
| -0 | 0 | -0 | 0 | 1 | -1 | 0 | |
| Free Cash Flow | 8 | -1 | 0 | 4 | -7 | 1 | 5 |
| OCF / Net Profit | 2.88 | 1.40 | 2.12 | 4.73 | -0.78 | 1.95 | 2.47 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -2 | 4 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| PER SHARE | |||||||
| EPS (₹) | 5.66 | 2.02 | 2.15 | 2.87 | 5.23 | 5.72 | 5.97 |
| Book Value (₹) | 22.62 | 24.63 | 26.79 | 29.76 | 44.30 | 49.37 | 54.84 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.40 | 0.50 |
| Cash EPS (₹) | 6.68 | 3.06 | 3.65 | 5.07 | 7.49 | 8.03 | 9.79 |
| PROFITABILITY | |||||||
| Operating Margin % | 2.95% | 1.92% | 2.33% | 3.28% | 4.14% | 3.44% | 2.92% |
| Net Margin % | 1.21% | 0.43% | 0.55% | 0.86% | 1.64% | 1.59% | 1.28% |
| ROE % | 25.03% | 8.54% | 8.38% | 10.15% | 15.82% | 12.22% | 11.46% |
| ROCE % | 24.67% | 13.84% | 11.27% | 11.43% | 16.11% | 13.41% | 12.96% |
| 3.12% | 1.13% | 1.27% | 1.81% | 4.03% | 3.43% | 3.03% | |
| EFFICIENCY | |||||||
| Debtor Days | 66 | 70 | 75 | 73 | 65 | 76 | 65 |
| Inventory Days | 51 | 44 | 52 | 62 | 46 | 53 | 50 |
| Payable Days | 124 | 98 | 93 | 91 | 75 | 93 | 91 |
| -7 | 17 | 35 | 43 | 36 | 36 | 24 | |
| FINANCIAL HEALTH | |||||||
| Debt to Equity (x) | 1.28x | 1.60x | 1.66x | 1.71x | 0.75x | 0.62x | 0.59x |
| Interest Coverage (x) | 2.82x | 1.54x | 1.65x | 1.84x | 2.72x | 4.05x | 3.88x |
| 1.12x | 1.18x | 1.23x | 1.23x | 1.39x | 1.26x | 1.21x | |
| GROWTH | |||||||
| Revenue Growth % | 0.00% | -0.22% | -16.90% | -0.87% | 31.43% | 12.53% | 29.76% |
| Operating Profit Growth % | 0.00% | -34.79% | 1.01% | 19.31% | 65.89% | -3.06% | 13.87% |
| Net Profit Growth % | 0.00% | -64.38% | 6.78% | 33.29% | 148.44% | 9.36% | 4.30% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 9.36% | 4.30% | |
| VALUATION | |||||||
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 10.91x | 19.47x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 1.27x | 2.12x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.64% | 0.43% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 7.17x | 10.02x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for ARISTO
Loading news…
AI Stock Analyst
Aristo Bio-Tech and Lifescience Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account